1. Home
  2. ONCY vs MAXN Comparison

ONCY vs MAXN Comparison

Compare ONCY & MAXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONCY
  • MAXN
  • Stock Information
  • Founded
  • ONCY 1998
  • MAXN 2019
  • Country
  • ONCY Canada
  • MAXN Singapore
  • Employees
  • ONCY N/A
  • MAXN N/A
  • Industry
  • ONCY Pharmaceuticals and Biotechnology
  • MAXN Semiconductors
  • Sector
  • ONCY Health Care
  • MAXN Technology
  • Exchange
  • ONCY Nasdaq
  • MAXN Nasdaq
  • Market Cap
  • ONCY 49.1M
  • MAXN 56.0M
  • IPO Year
  • ONCY 1999
  • MAXN N/A
  • Fundamental
  • Price
  • ONCY $0.52
  • MAXN $3.14
  • Analyst Decision
  • ONCY Strong Buy
  • MAXN Sell
  • Analyst Count
  • ONCY 3
  • MAXN 3
  • Target Price
  • ONCY $4.33
  • MAXN $101.33
  • AVG Volume (30 Days)
  • ONCY 333.0K
  • MAXN 154.5K
  • Earning Date
  • ONCY 05-14-2025
  • MAXN 05-19-2025
  • Dividend Yield
  • ONCY N/A
  • MAXN N/A
  • EPS Growth
  • ONCY N/A
  • MAXN N/A
  • EPS
  • ONCY N/A
  • MAXN N/A
  • Revenue
  • ONCY N/A
  • MAXN $509,048,000.00
  • Revenue This Year
  • ONCY N/A
  • MAXN $74.20
  • Revenue Next Year
  • ONCY N/A
  • MAXN $21.79
  • P/E Ratio
  • ONCY N/A
  • MAXN N/A
  • Revenue Growth
  • ONCY N/A
  • MAXN N/A
  • 52 Week Low
  • ONCY $0.47
  • MAXN $2.49
  • 52 Week High
  • ONCY $1.53
  • MAXN $410.00
  • Technical
  • Relative Strength Index (RSI)
  • ONCY 41.53
  • MAXN 50.18
  • Support Level
  • ONCY $0.54
  • MAXN $2.72
  • Resistance Level
  • ONCY $0.65
  • MAXN $3.43
  • Average True Range (ATR)
  • ONCY 0.04
  • MAXN 0.31
  • MACD
  • ONCY -0.00
  • MAXN 0.02
  • Stochastic Oscillator
  • ONCY 13.36
  • MAXN 47.79

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.

About MAXN Maxeon Solar Technologies Ltd.

Maxeon Solar Technologies Ltd is engaged in the manufacturing and marketing of premium solar technology. It owns and operates solar cell and panel manufacturing facilities located in Malaysia, Mexico, and the Philippines. The company's primary products are the Maxeon line of interdigitated back contact (IBC) solar cells and panels, and the Performance line (formerly, P-Series) of shingled solar cells and panels. the Maxeon line of solar panels are the highest-efficiency solar panels on the market with an aesthetically pleasing design, and the Performance line of solar panels offers a high-value and cost-effective solution. It is targeted at residential and small-scale commercial customers across the globe. The company derives its revenue from the United States, France, Italy, and others.

Share on Social Networks: